Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...] …
Category: General
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although the bulk of recent 340B-related legislative action has occurred in statehouses across the country, 340B advocates and stakeholders are [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rhode Island could soon become the next state to pass legislation with 340B contract pharmacy protections and reporting requirements, as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …